6UE9 image
Deposition Date 2019-09-20
Release Date 2020-02-19
Last Version Date 2024-10-23
Entry Detail
PDB ID:
6UE9
Keywords:
Title:
Structure of tetrameric sIgA complex (Class 2)
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.90 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Immunoglobulin heavy constant alpha 2
Gene (Uniprot):IGHA2
Chain IDs:A, B, E (auth: F), F (auth: G), G (auth: E), H, I (auth: K), J (auth: L)
Chain Length:245
Number of Molecules:8
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Polymeric immunoglobulin receptor
Gene (Uniprot):PIGR
Chain IDs:C
Chain Length:591
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Immunoglobulin J chain
Gene (Uniprot):JCHAIN
Chain IDs:D
Chain Length:137
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Structure of the secretory immunoglobulin A core.
Science 367 1008 1014 (2020)
PMID: 32029686 DOI: 10.1126/science.aaz5807

Abstact

Secretory immunoglobulin A (sIgA) represents the immune system's first line of defense against mucosal pathogens. IgAs are transported across the epithelium, as dimers and higher-order polymers, by the polymeric immunoglobulin receptor (pIgR). Upon reaching the luminal side, sIgAs mediate host protection and pathogen neutralization. In recent years, an increasing amount of attention has been given to IgA as a novel therapeutic antibody. However, despite extensive studies, sIgA structures have remained elusive. Here, we determine the atomic resolution structures of dimeric, tetrameric, and pentameric IgA-Fc linked by the joining chain (JC) and in complex with the secretory component of the pIgR. We suggest a mechanism in which the JC templates IgA oligomerization and imparts asymmetry for pIgR binding and transcytosis. This framework will inform the design of future IgA-based therapeutics.

Legend

Protein

Chemical

Disease

Primary Citation of related structures